The IMvigor010 trial showed that Signatera-guided treatment with Tecentriq improved disease-free survival and overall ...

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...

Mitchell, who has served as a councilman for 23 years, was diagnosed with bladder cancer in February after previously being ...

A new slow-release implant has shown unprecedented success in wiping out bladder cancer in more than 80 percent of patients, ...

The experts agreed that perioperative approaches in muscle-invasive bladder cancer continue to evolve. Ongoing data will ...

The LEGEND trial showed a 62% complete response (CR) rate with the non-viral gene therapy at six months in NMIBC patients who ...

Emmanuel Acho criticizes Deion Sanders’ coaching amid colorado’s struggles originally appeared on The Sporting News. Add The ...

A former ketamine addict has said the drug ‘should be up there with crack and heroin’ after he had to have surgery to remove ...

Sehrawat is a life convict in the 1984 anti-Sikh riots case. This case is linked with killing of Sikhs in the Mahipalpur area. He was sentenced to life imprisonment in 2018 by a Special Jauge at ...

An innovative new treatment option for bladder cancer, recently approved by the U.S. Food and Drug Administration, has been performed for the first time in Maryland.

A slow drug-release system has proven highly effective in treating certain bladder cancer patients whose tumors were previously unresponsive to therapy. A new targeted drug delivery system known as TA ...